4598 Delta-Fly Pharma
- 514
- -14-2.65%
Delta-Fly Pharma News
Delta-Fly Pharma: Change reports (stock certificates subject to special cases, etc.)
Delta-Fly Pharma: 2025 President's New Year's Greetings (Notice regarding progress of major development products)
Delta-Fly Pharma: Change reports (stock certificates subject to special cases, etc.)
Delta-Fly Pharma: Large holding reports (stock certificates subject to special cases, etc.)
Delta-Fly Pharma: change report
Delta-Fly Pharma: Notice regarding completion of exercise of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses) and monthly exercise status
Delta-Fly Pharma: Notice Concerning Mass Exercise of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses)
Delta-Fly Pharma: Notice regarding clinical trial status of DFP-10917+VEN+ and DFP-10917
Delta-Fly Pharma: Notice regarding the development status of DFP-17729
Delta-Fly Pharma: change report
Delta-Fly Pharma: Notice regarding the monthly exercise status of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses)
Delta-Fly Pharma: Notice Concerning Mass Exercise of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses)
Delta-Fly Pharma: Notice regarding the clinical phase 3 comparative trial of DFP-14323
Delta-Fly Pharma: Confirmatory letter.
Delta-Fly Pharma: Half Year Report - Term 15 (2024/04/01 - 2025/03/31)
Delta-Fly Pharma: Notice regarding responses to inquiries
Delta-Fly Pharma: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
Delta-Fly Pharma: 2Q financial results presentation materials for the fiscal year ending 2025/3 20241114
Delta-Fly Pharma: change report
Delta-Fly Pharma: change report
No Data